Welcome to our dedicated page for Credo Technology Group Holding SEC filings (Ticker: CRDO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Credo Technology Group Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Credo Technology Group Holding's regulatory disclosures and financial reporting.
Credo Technology Group Holding Ltd preannounced stronger-than-expected results for the third quarter of fiscal 2026. The company expects revenue between $404 million and $408 million, above its earlier guidance range of $335 million to $345 million.
Credo also now expects sequential revenue growth in the mid-single digits and projects more than 200% year-over-year revenue growth for the current fiscal year. The company will discuss full results for the quarter ended January 31, 2026 on a conference call scheduled for March 2, 2026 at 2:00 p.m. Pacific Time.
Credo Technology Group Holding Ltd director and Chief Technology Officer Cheng Chi Fung reported multiple sales of ordinary shares on January 29, 2026, executed by the Cheng Huang Family Trust under a pre-arranged Rule 10b5-1 trading plan adopted on September 5, 2025.
The trust, of which Cheng Chi Fung and his spouse are trustees and beneficiaries along with their children, carried out a series of open-market sales at weighted average prices ranging from $123.9559 to $134.335 per share, leaving 6,299,870 ordinary shares held indirectly by the trust and 111,220 ordinary shares held directly following the reported transactions. The reporting person disclaims beneficial ownership of the trust shares except to the extent of his and his spouse's pecuniary interest.
Credo Technology Group Holding Ltd President and Chief Executive Officer William Joseph Brennan reported multiple sales of ordinary shares dated January 29, 2026, executed under a pre-arranged Rule 10b5-1 trading plan adopted on April 15, 2025.
The filing shows a series of open-market sales of Credo ordinary shares held directly by Brennan and indirectly through The Brennan Family Trust, DTD 09/06/2002. After the reported transactions, Brennan directly held 252,625 ordinary shares, while the trust held 1,832,502 ordinary shares, with Brennan disclaiming beneficial ownership of the trust’s shares except to the extent of his pecuniary interest.
Credo Technology Group Holding Ltd director share sale under 10b5-1 plan
Director Pantas Sutardja reported selling 1,875 Ordinary Shares of Credo Technology Group Holding Ltd on January 30, 2026 at $128.67 per share. After this trade, he beneficially owned 5,892,034 Ordinary Shares, held directly.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on June 26, 2025, which allows systematic transactions set up in advance.
Credo Technology Group Holding Ltd insider activity: A family trust associated with Chief Technology Officer and director Cheng Chi Fung reported selling an aggregate of 30,000 ordinary shares of CRDO on January 22, 2026. The Cheng Huang Family Trust executed multiple open-market sales under a pre-established Rule 10b5-1 trading plan adopted on September 5, 2025, at weighted average prices ranging from $133.1482 to $143.54 per share.
Following these transactions, the trust held 6,327,370 ordinary shares, reported as indirectly owned, while an additional 111,220 ordinary shares were reported as directly owned. The filing notes that the shares held by the trust are for the benefit of Cheng Chi Fung, his spouse and their children, and states that he disclaims beneficial ownership except to the extent of his and his spouse's pecuniary interest.
BlackRock, Inc. has filed an amended Schedule 13G reporting its beneficial ownership of common stock of Credo Technology Group Holding Ltd. BlackRock reports beneficial ownership of 16,281,934 Credo common shares, representing 9.0% of the class as of the event date. It reports sole voting power over 15,662,866 shares and sole dispositive power over 16,281,934 shares, with no shared voting or dispositive power.
The filing explains that various underlying clients and investors have the right to receive dividends or sale proceeds from these shares, but no single person has an interest in more than five percent of Credo’s outstanding common shares. BlackRock states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Credo.
Credo Technology Group Holding Ltd reported an insider transaction involving the Cheng Huang Family Trust, an entity associated with Chief Technology Officer and director Cheng Chi Fung. On January 15, 2026, the trust sold a total of 30,000 ordinary shares in multiple open-market trades under a pre-arranged Rule 10b5-1 trading plan. The sales occurred at weighted average prices ranging from $149.10 to $164.06 per share. After these transactions, the trust held 6,357,370 ordinary shares indirectly, and Cheng Chi Fung also held 111,220 ordinary shares directly, while disclaiming beneficial ownership of the trust shares except to the extent of his and his spouse's pecuniary interest.
Credo Technology Group Holding Ltd director Sylvia Acevedo reported selling a total of 2,200 ordinary shares of CRDO on January 13, 2026. The Form 4 shows two open-market sales of 1,100 shares each, at prices of $162.11 and $156.25 per share. After these transactions, Acevedo directly beneficially owned 18,545 ordinary shares of Credo. All reported holdings are listed as directly owned, with no derivative securities reported.
Sylvia Acevedo filed a notice of proposed sale of common stock. The filing covers 2,200 common shares to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $350,196.00, on or about 01/13/2026 on the NASDAQ exchange. These 2,200 shares were acquired as restricted stock from the issuer on 10/13/2025, with payment made the same day.
The notice also reports that Sylvia Acevedo previously sold 1,875 common shares on 12/05/2025 for gross proceeds of $347,193.75. The issuer reports 180,631,719 shares or units outstanding, providing context for the size of the planned sale.
Credo Technology Group Holding Ltd director and Chief Technology Officer Cheng Chi Fung reported multiple sales of ordinary shares on January 8, 2026. The transactions were executed by the Cheng Huang Family Trust under a Rule 10b5-1 trading plan adopted on September 5, 2025. The trust sold several blocks of shares at weighted average prices between approximately $135 and $143 per share in open market transactions. Following these sales, the trust held 6,387,370 ordinary shares, and Cheng Chi Fung also held 111,220 ordinary shares directly. The filing notes that he and his spouse are trustees of the trust and that he disclaims beneficial ownership except to the extent of their pecuniary interest.